The Pharma Legal Handbook: India

India is the world's third largest pharmaceutical market by volume and one of its most complex regulatory environments. The Central Drugs Standard Control Organisation (CDSCO) manages product registration at the national level, while State Drug Authorities handle manufacturing licences and retail distribution, creating a dual regulatory structure that companies need to navigate at both levels.

India's price control system, administered by the National Pharmaceutical Pricing Authority (NPPA), covers essential medicines under the Drugs Price Control Order and applies ceiling prices based on market-based mechanisms. Understanding which products are subject to price control, how ceiling prices are calculated, and what the obligations are around price notifications is essential for commercial planning.

The Pharma Legal Handbook: India provides comprehensive guidance on pharmaceutical regulation in India, covering CDSCO product registration, NPPA pricing regulations, clinical trial requirements under the New Drugs and Clinical Trials Rules, pharmacovigilance obligations, manufacturing and GMP requirements, marketing rules, and intellectual property protection.